Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenyl-uridine-5'-diphosphate is a synthetic small molecule, a nucleoside diphosphate derivative. It is structurally related to uridine diphosphate (UDP), a naturally occurring nucleotide involved in various cellular processes including energy metabolism, signal transduction, and the synthesis of polysaccharides and nucleic acids. While its precise biological activity and specific mechanism of action are not extensively detailed in publicly available literature, related uridine nucleotides are known to interact with P2Y G protein-coupled receptors, acting as either agonists or antagonists. The addition of a phenyl group to the uridine-5'-diphosphate structure likely modifies its pharmacological properties compared to the unmodified compound. It is primarily identified as a chemical compound in databases and is classified as a pharmaceutical in ZINC15, suggesting potential interest in drug discovery and research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Phenyl-uridine-5'-diphosphate.